Home Newsfeeds Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

Chardan Capital Maintains Buy on PLBY Group, Lowers Price Target to $9

By Benzinga Newsdesk

August 10, 10:09 AM

Chardan Capital analyst Brian Dobson maintains PLBY Group (NASDAQ:PLBY) with a Buy and lowers the price target from $13 to $9.

PLBY

As Bitcoin Surges Over $50K, Ethereum, Dogecoin Join The Rally — Analyst Predicts New Price Target Of $130K For King Crypto

By Mehab Qureshi

February 12, 11:10 PM

Major cryptocurrencies surged on Monday evening, rebounding swiftly after a temporary setback subsequent to the launch of spot ETFs on January 11. The crypto bull market, which commenced in January 2023, has now advanced into the FOMO stage.

$DOGE

Analyst Ratings

What 6 Analyst Ratings Have To Say About McKesson

By Benzinga Insights

August 4, 2:16 PM

Over the past 3 months, 6 analysts have published their opinion on McKesson (NYSE:MCK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

MCK

Concerned Shareholders Of Cano Health Issue Open Letter Regarding The Board’s Entrenchment Maneuvers And Latest Governance Failures

By Happy Mohamed

April 26, 8:33 AM

Group Believes Board Has Disregarded Shareholders' Concerns by Appointing Solomon Trujillo as "Independent" Chairman Highlights Conflicting Financial Arrangements and Interlocks Among Board Members,

CANO

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Related Posts

Chardan Capital Maintains Buy on PLBY Group, Lowers Price Target to $9

As Bitcoin Surges Over $50K, Ethereum, Dogecoin Join The Rally — Analyst Predicts New Price Target Of $130K For King Crypto

What 6 Analyst Ratings Have To Say About McKesson

Concerned Shareholders Of Cano Health Issue Open Letter Regarding The Board’s Entrenchment Maneuvers And Latest Governance Failures